Selina Fillinger’s frantic seven-woman farce “POTUS” has a subtitle that flaunts its feminist flair: “POTUS” (short, of course, for “president of the United States”) is followed by “Or, Behind Every ...

Early in the Covid-19 pandemic, the governor of New Jersey made an unusual admission: He’d run out of COBOL developers. The state’s unemployment insurance systems were written in the 60-year-old ...

Abstract: Heuristic dispatching rules (HDRs) are widely used for solving the dynamic fuzzy job shop scheduling problem. However, their performance is highly sensitive to specific scenarios and often ...

Over the last year, Sanofi has been busy reshaping itself to focus more on innovative drugs, including selling a controlling stake in its former consumer business and using those proceeds to strike a ...

WASHINGTON – Democrats’ counterprogramming event to President Trump’s State of the Union address was hijacked by MAGA supporters and liberals dressed up like frogs — chirping “ribbit.” Activists and ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Caption: Novo Nordisk Canada is considering competing with generic versions of its Ozempic and Wegovy drugs by introducing renamed, lower-priced copies of the medications. (Jan. 7, 2026) Trump's ...

TORONTO — Novo Nordisk Canada is considering competing with generic versions of its brand-name Ozempic and Wegovy drugs by introducing renamed, lower-priced copies of the medications. Health Canada ...

Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. The adoption rate of AI ...

Magic is real, and we know this because science could never replicate the process that gave us Getting Killed. A bunch of talented Brooklyn teenagers emerge from the pandemic with a promising ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...